Summit Financial Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
10,611
+754
+8% +$88.3K 0.17% 71
2026
Q1
$1.19M Sell
9,857
-6
-0.1% -$693 0.17% 69
2025
Q4
$1.04M Sell
9,863
-161
-2% -$15.1K 0.15% 76
2025
Q3
$903K Buy
10,024
+345
+4% +$28.4K 0.14% 70
2025
Q2
$766K Buy
9,679
+872
+10% +$69.3K 0.14% 72
2025
Q1
$790K Sell
8,807
-767
-8% -$71.6K 0.16% 67
2024
Q4
$955K Sell
9,574
-62,998
-87% -$6.49M 0.19% 62
2024
Q3
$8.24M Buy
72,572
+762
+1% +$90.5K 1.55% 22
2024
Q2
$8.89M Sell
71,810
-2,175
-3% -$280K 1.8% 17
2024
Q1
$9.76M Buy
73,985
+1,605
+2% +$198K 1.98% 14
2023
Q4
$7.89M Sell
72,380
-316
-0.4% -$32.8K 1.79% 18
2023
Q3
$7.56M Sell
72,696
-1,182
-2% -$127K 1.86% 16
2023
Q2
$8.52M Sell
73,878
-3,242
-4% -$368K 1.97% 16
2023
Q1
$8.2M Sell
77,120
-79
-0.1% -$8.53K 1.95% 16
2022
Q4
$8.57M Buy
77,199
+57
+0.1% +$5.83K 2.07% 15
2022
Q3
$7.69M Buy
77,142
+3,642
+5% +$325K 2.21% 15
2022
Q2
$6.65M Buy
73,500
+1,633
+2% +$145K 1.59% 23
2022
Q1
$5.9M Buy
71,867
+4,540
+7% +$358K 1.19% 30
2021
Q4
$5.18M Buy
67,327
+6,882
+11% +$548K 1% 29
2021
Q3
$4.54M Buy
60,445
+5,160
+9% +$392K 1.03% 29
2021
Q2
$4.3M Buy
55,285
+797
+1% +$59.3K 0.97% 29
2021
Q1
$4.25M Buy
54,488
+2,022
+4% +$149K 1.08% 27
2020
Q4
$4.15M Sell
52,466
-4,459
-8% -$341K 1.13% 26
2020
Q3
$4.17M Sell
56,925
-456
-0.8% -$35.7K 1.11% 26
2020
Q2
$4.27M Buy
57,381
+2,610
+5% +$196K 1.14% 26
2020
Q1
$4.2M Buy
54,771
+574
+1% +$45.1K 1.32% 23
2019
Q4
$4.45M Buy
54,197
+409
+0.8% +$33.6K 1.08% 28
2019
Q3
$4.33M Buy
53,788
+7,629
+17% +$611K 1.06% 26
2019
Q2
$3.69M Buy
46,159
+10,423
+29% +$798K 0.9% 31
2019
Q1
$2.84M Buy
35,736
+986
+3% +$73.7K 0.75% 42
2018
Q4
$2.53M Buy
34,750
+3,518
+11% +$248K 0.82% 37
2018
Q3
$2.07M Buy
31,232
+7,487
+32% +$477K 0.62% 47
2018
Q2
$1.23M Sell
23,745
-1,121
-5% -$63.2K 0.41% 57
2018
Q1
$1.29M Buy
24,866
+3,977
+19% +$215K 0.42% 56
2017
Q4
$1.12M Buy
20,889
+1,363
+7% +$75.6K 0.39% 61
2017
Q3
$1.19M Buy
19,526
+2,323
+14% +$141K 0.43% 60
2017
Q2
$1.05M Buy
17,203
+4,887
+40% +$297K 0.42% 62
2017
Q1
$747K Sell
12,316
-443
-3% -$26.9K 0.33% 74
2016
Q4
$717K Buy
12,759
+90
+0.7% +$5.27K 0.32% 77
2016
Q3
$754K Buy
12,669
+263
+2% +$15.4K 0.33% 68
2016
Q2
$682K Buy
12,406
+4,258
+52% +$227K 0.28% 78
2016
Q1
$411K Buy
8,148
+1,110
+16% +$54.4K 0.18% 100
2015
Q4
$355K Buy
7,038
+4,135
+142% +$208K 0.16% 98
2015
Q3
$136K Hold
2,903
0.09% 92
2015
Q2
$157K Hold
2,903
0.1% 91
2015
Q1
$164K Hold
2,903
0.11% 75
2014
Q4
$157K Buy
+2,903
New +$162K 0.11% 76

Other funds holding MRK

Summit Financial Wealth Advisors's MRK Position: Q2 2026 in Review

Summit Financial Wealth Advisors increased its Merck (MRK) stake by 7.6% in Q2 2026, buying an estimated $88.3K and bringing the position to 10,611 shares worth $1.36M. The position accounts for 0.17% of the portfolio, ranked #71.

Summit Financial Wealth Advisors first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. The position peaked at $9.76M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Summit Financial Wealth Advisors held 10,611 shares of Merck worth $1.36M as of Q2 2026.
  • Summit Financial Wealth Advisors bought 754 Merck shares in Q2 2026, an estimated $88.3K.
  • Merck made up 0.17% of Summit Financial Wealth Advisors's portfolio in Q2 2026, its #71 holding.
  • Summit Financial Wealth Advisors first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
  • Summit Financial Wealth Advisors's Merck position peaked at $9.76M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Summit Financial Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.